Spots Global Cancer Trial Database for metastatic neuroendocrine neoplasm
Every month we try and update this database with for metastatic neuroendocrine neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors | NCT04079712 | Metastatic Larg... Metastatic Neur... Metastatic Neur... Metastatic Smal... | Cabozantinib S-... Ipilimumab Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor | NCT04810091 | Locally Advance... Metastatic Neur... | Placebo Adminis... Questionnaire A... Telotristat Eth... | 18 Years - | M.D. Anderson Cancer Center |